A growing body of evidence through our experiments provides concrete data that inhibition of autophagy with 3-MA or HCQ followed by concomitant treatment with anti-EGFR mAbs and checkpoint inhibitors have a synergistic anti-tumor effect. The gene discussed is EGFR; the disease is neoplasm.